ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 180 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,898 | -3.0% | 13,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $48,339 | -99.1% | 13,100 | -99.2% | 0.00% | -99.3% |
| Q1 2023 | $5,273,161 | -48.5% | 1,593,100 | -39.6% | 0.14% | -47.2% |
| Q4 2022 | $10,239,708 | +72.0% | 2,639,100 | +7.7% | 0.26% | +66.7% |
| Q3 2022 | $5,954,000 | +1042.8% | 2,450,300 | +831.3% | 0.16% | +1225.0% |
| Q2 2022 | $521,000 | +8.3% | 263,100 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $481,000 | +2572.2% | 263,100 | +1908.4% | 0.01% | – |
| Q4 2021 | $18,000 | -93.9% | 13,100 | -95.0% | 0.00% | -100.0% |
| Q3 2021 | $297,000 | -48.9% | 263,100 | -27.5% | 0.01% | -40.0% |
| Q2 2021 | $581,000 | -39.2% | 363,100 | -33.1% | 0.01% | -44.4% |
| Q1 2021 | $956,000 | – | 543,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |